Quarterly results round-up: good quarter for Varian, while Zimmer earnings growth gives cause for concern
This article was originally published in Clinica
Executive Summary
Alere's takeover of Axis-Shield is now almost complete after it increased its stake to 91%, allowing it to compulsorily purchase all shares in the Anglo-Nordic firm. This will bring to a close the long-running takeover battle, which started in July when Alere made its initial offer of 460p per share, valuing the deal at £230m ($375m) in total (www.clinica.co.uk, 6 July 2011).